Aucubin, an iridoid glycoside was found to suppress hepatitis B virus DNA replication in vitro in a 2.2.15 cell culture system. Aucubin itself did not exhibit antiviral activity, but it showed significant activity when preincubated with -glucosidase. Aucubin possesses no cytotoxicity at a broad ran
Antiviral activity of 2,3′-anhydro and related pyrimidine nucleosides against hepatitis B virus
✍ Scribed by Naveen C. Srivastav; Michelle Mak; Babita Agrawal; D. Lorne J. Tyrrell; Rakesh Kumar
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 264 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
✦ Synopsis
Various 2,3'-anhydro analogs of 5-substituted 1-(2-deoxy-β-d-lyxofuranosyl)uracils (10-15) and a related 1-(3-O-mesyl-2-deoxy-β-d-lyxofuranosyl) pyrimidine nucleoside analog (18) have been synthesized for evaluation as a new class of potential anti-HBV agents. The compounds 10, 12, and 15 demonstrated most potent anti-HBV activities against duck HBV (DHBV) and human HBV with EC(50) values in the range of 2.5-10 and 5-10 μg/mL, respectively, at non-toxic concentrations (CC(50) = > 200 μg/mL). The nucleoside 18 also demonstrated significant anti-HBV activity against DHBV with an EC(50) value of 2.5 μg/mL, however, it was less active against HBV in 2.2.15 cells (EC(50) = > 10 μg/mL).
📜 SIMILAR VOLUMES
Nucleoside analogues containing a 2-deoxy-l,5-anhydro-D-mannitol and a pyrimidine base moiety were synthesized starting from D-glucose via a nucleophilie opening of an epoxide with the heterocyelic base and an inversion of configuration at the 3'-position. Study of the conformation of these molecule
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v
lipid prodrugs to target the liver may be useful in en-It would be desirable to develop antiviral agents that hancing antiviral therapy of hepatitis. (HEPATOLOGY can be targeted to liver to enhance their antiviral effects 1996;23:958-963.) and reduce nonhepatic toxicity. 2,3-Dideoxyguanosine (ddG) h